Cartesian Therapeutics, Inc. (RNAC)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$6.78-0.59%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · RNAC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | — | 2.8 | 38.9 | 26.0 | 110.8 | 85.1 | 16.6 | 6.7 | 8.1 |
| Total Revenues | — | 2.8 | 38.9 | 26.0 | — | — | — | — | 8.1 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 70.2 | 58.0 | 45.1 | 71.3 | 72.4 | 68.7 | 54.5 | 42.7 | 29.7 |
| Operating Income | (159.3) | (143.4) | (43.9) | (86.4) | 14.5 | (4.6) | (56.8) | (52.5) | (34.7) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | 2.8 | 3.0 | 2.8 | 1.6 | 1.5 | 1.3 |
| Interest & Investment Income | — | 6.6 | 7.4 | 5.0 | — | — | — | — | — |
| Net Interest Expenses | — | — | — | (2.1) | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | 3.9 | — | — | — | — | — | — | — |
| Asset Writedown | — | — | 7.6 | 0.7 | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (139.5) | (77.1) | (238.7) | 34.8 | (9.7) | (68.9) | — | — |
| Income Tax Expense | — | (9.2) | 0.3 | (19.0) | (0.6) | 16.0 | 0.0 | — | — |
| Net Income | |||||||||
| Net Income | (127.5) | (130.3) | (77.4) | (219.7) | 35.4 | (25.7) | (68.9) | (55.4) | (36.2) |
| Per Share | |||||||||
| Basic EPS | (4.21) | (5.02) | (4.48) | (49.76) | 0.24 | (0.22) | (0.68) | — | — |
| Diluted EPS | (4.21) | (5.02) | (4.49) | (49.76) | 0.10 | (0.22) | (0.68) | — | — |
| Basic Weighted Avg Shares | 30.3 | 26.0 | 17.3 | 5.2 | 144.8 | 114.3 | 101.2 | — | — |
| Diluted Weighted Avg Shares | 30.3 | 26.0 | 17.4 | 5.2 | 145.9 | 114.3 | 101.2 | — | — |
| Supplemental | |||||||||
| EBIT | (159.3) | (143.4) | (43.9) | (86.4) | 14.5 | (4.6) | (56.8) | (52.5) | (34.7) |
| Effective Tax Rate | — | — | — | 8.0% | -1.8% | -164.2% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.